By Counterforce Health Team in Emflaza (deflazacort) —

How to Get Emflaza (deflazacort) Covered by Aetna (CVS Health) in New Jersey: Prior Authorization Guide and Appeals Process

Answer Box: Getting Emflaza (deflazacort) Covered by Aetna (CVS Health) in New Jersey

Aetna requires prior authorization for Emflaza (deflazacort) with documented DMD diagnosis and failed trial of prednisone/prednisolone due to weight gain or behavioral issues. Submit genetic testing, prior steroid records, and medical necessity letter through CVS Caremark portal. If denied, appeal within 180 days internally, then use New Jersey's IHCAP external review administered by Maximus Federal Services.

First step today: Contact your prescriber to gather DMD genetic testing results and document any prednisone/prednisolone side effects for the prior authorization submission.

Table of Contents

  1. When Emflaza Alternatives Make Sense
  2. Typical DMD Corticosteroid Alternatives
  3. Pros and Cons Overview
  4. Exception Strategy for Emflaza
  5. Switching Logistics
  6. Re-trying for Emflaza Later
  7. Prior Authorization Requirements
  8. Appeals Process in New Jersey
  9. Cost-Saving Options
  10. FAQ

When Emflaza Alternatives Make Sense

Before pursuing a costly appeal process, consider whether Aetna's preferred DMD corticosteroids might work for your situation. Prednisone and prednisolone are Aetna's first-line corticosteroids for Duchenne muscular dystrophy, covered with minimal restrictions and proven effective in slowing disease progression.

Alternatives make sense when:

  • Cost is a primary concern (generics cost $20-50/month vs. Emflaza's $9-12 per tablet)
  • Prior authorization delays are unacceptable for immediate treatment needs
  • No previous steroid intolerance has been documented
  • Weight management strategies can be implemented alongside treatment

However, stick with pursuing Emflaza if:

  • Previous prednisone/prednisolone caused unmanageable weight gain (BMI ≥85th percentile)
  • Persistent behavioral issues lasted >6 weeks on other steroids
  • Bone density concerns or cataract risk factors are present

Typical DMD Corticosteroid Alternatives

First-Line Aetna-Covered Options

Prednisone (generic)

  • Dosing: 0.75 mg/kg/day (standard DMD protocol)
  • Coverage: Tier 1 generic, no prior authorization typically required
  • Availability: All pharmacies; 30-day supplies common

Prednisolone (generic)

  • Dosing: 0.75 mg/kg/day
  • Coverage: Tier 1 generic, minimal restrictions
  • Forms: Tablets and liquid suspension available

Advanced DMD Therapies (Require Separate PA)

For patients with specific genetic mutations, Aetna covers exon-skipping therapies like eteplirsen (Exondys 51), but these require:

  • Genetic confirmation of amenable mutations
  • Specialist prescription from neuromuscular physician
  • Separate prior authorization process
  • Are not corticosteroid alternatives

Pros and Cons Overview

Medication Access Advantages Monitoring Considerations
Prednisone Immediate coverage, low cost, widely available More weight gain, behavioral changes, requires regular growth/bone monitoring
Prednisolone Similar to prednisone, liquid form for younger children Same monitoring as prednisone
Emflaza (deflazacort) Less weight gain, may delay ambulation loss longer Higher cataract risk (15% real-world), more bone density issues, requires PA

Side Effect Comparison (52-week clinical trial data)

  • Weight gain: Deflazacort causes smaller BMI increases vs. prednisone (27.9% vs. 34.9% incidence)
  • Growth suppression: Higher with deflazacort (37% real-world) vs. prednisone
  • Cataracts: 4.4% deflazacort vs. 1.6% prednisone in trials; 15% in real-world deflazacort use
  • Bone density: Weaker bones more common with deflazacort (22% real-world)

Exception Strategy for Emflaza

When to Request an Exception

File for Emflaza when you have documented evidence of:

  1. Step therapy failure: Prednisone/prednisolone trial with unmanageable side effects
  2. Medical necessity: Specific clinical reasons deflazacort is preferred
  3. Specialist support: Neuromuscular physician recommendation

Evidence That Strengthens Your Case

Clinical Documentation

  • Genetic testing confirming DMD gene mutation
  • Growth charts showing excessive weight gain on prednisone (BMI percentile ≥85th)
  • Behavioral assessment documenting psychiatric issues >6 weeks
  • Bone density scans if applicable

Medical Literature

  • FDA approval for DMD ages 2+ (Emflaza prescribing information)
  • Real-world studies showing delayed ambulation loss
  • Comparative safety profiles from peer-reviewed studies
From our advocates: One family's successful appeal included detailed growth charts showing their 8-year-old moved from 50th to 95th BMI percentile on prednisone over 4 months, plus school behavioral reports documenting aggression. The combination of objective weight data and functional impact documentation helped overturn the initial denial.

Switching Logistics

Coordination with Provider

Before switching from Emflaza to alternatives:

  1. Taper schedule: Never stop corticosteroids abruptly; follow provider's weaning protocol
  2. Monitoring setup: Establish baseline measurements (weight, height, bone density, vision)
  3. Emergency plan: Know signs of adrenal insufficiency during transitions

Pharmacy coordination:

  • Transfer prescriptions to preferred network pharmacy
  • Confirm generic availability and pricing
  • Set up refill reminders for consistent dosing

Insurance Transition Steps

  1. Notify Aetna: Report medication change through member portal
  2. Update prior authorizations: Cancel Emflaza PA if approved
  3. Confirm coverage: Verify new medication tier and copay
  4. Document trial: Keep detailed records for future Emflaza appeals

Re-trying for Emflaza Later

What to Document During Alternative Trials

Weight and Growth Tracking

  • Weekly weights for first month, then monthly
  • Height measurements every 3 months
  • BMI percentile calculations
  • Photos documenting Cushingoid features if they develop

Behavioral Monitoring

  • Daily mood/behavior logs
  • School performance reports
  • Sleep pattern changes
  • Social interaction impacts

Clinical Markers

  • Muscle strength assessments
  • Pulmonary function tests
  • Bone density monitoring
  • Vision screening

Timing Your Re-appeal

Optimal timing for new Emflaza request:

  • After 3-6 months of documented alternative steroid side effects
  • When functional decline accelerates despite treatment
  • If new clinical evidence supports deflazacort preference
  • During annual plan renewal periods

Prior Authorization Requirements

Aetna's Emflaza PA Criteria

Initial Approval (6 months)

  • Age ≥2 years (FDA indication)
  • Genetic mutation in DMD gene or absent dystrophin on muscle biopsy
  • Prior trial of prednisone/prednisolone with documented:
    • Weight gain/obesity (BMI ≥85th percentile) OR
    • Psychiatric/behavioral issues persisting >6 weeks
  • Dosing typically ≤0.9 mg/kg/day

Continuation Approval (12 months)

  • Meets initial criteria
  • Clinical benefit: improvement/stabilization in muscle strength or pulmonary function

Required Documentation

Submit through Aetna provider portal or CVS Caremark:

  • Genetic testing or muscle biopsy confirming DMD
  • Patient details: Age, weight, current functional status
  • Prednisone/prednisolone records: Side effects, duration, failure documentation
  • Medical necessity letter referencing FDA labeling and DMD guidelines
  • Weight-based dosing calculation if exceeding 0.9 mg/kg/day

Processing timeline: Standard 30-45 days; expedited 72 hours for urgent cases.

Appeals Process in New Jersey

Internal Appeals with Aetna

Level 1 Appeal

  • Deadline: Within 180 days of denial
  • Submission: Aetna member portal or provider fax
  • Timeline: 30 days for standard, 72 hours for expedited
  • Success rate: Approximately 50% when proper documentation included

Level 2 Appeal

  • Automatic: If Level 1 denied
  • Timeline: Additional 30 days
  • Decision: Final internal determination

New Jersey External Review (IHCAP)

After exhausting internal appeals, New Jersey offers excellent external review through the Independent Health Care Appeals Program (IHCAP), now administered by Maximus Federal Services.

Key Details:

  • Deadline: 4 months (180 days) from final internal denial
  • Cost: Free to patients (insurer pays all fees)
  • Success rate: Approximately 50% of external appeals favor consumers nationwide
  • Timeline: 5 business days for acceptance, ≤45 days for decision

How to Submit:

  • Online: [njpicpa.maximus.com](verify with the source linked below)
  • Phone: 1-888-393-1062 or NJ DOBI Hotline 1-800-446-7467
  • Required documents: Final denial letter, medical records, physician letter justifying medical necessity

Expedited Review: Available when delay would cause serious harm; physician certification required. Decision typically within 48-72 hours.

Note: Providers can file external appeals on behalf of patients with consent, and appeals are allowed even for services already provided and denied.

Cost-Saving Options

While pursuing coverage, explore these financial assistance options:

Manufacturer Support

  • Contact PTC Therapeutics for patient assistance programs (verify current eligibility at [manufacturer website](verify with the source linked below))

Prescription Discount Programs

  • GoodRx estimates: 6-mg tablets approximately $9-12 per tablet
  • Actual costs vary by strength, quantity, and pharmacy

Specialty Pharmacy Options

  • CVS Specialty Pharmacy handles Emflaza dispensing
  • May offer coordination with assistance programs

FAQ

How long does Aetna prior authorization take in New Jersey? Standard PA decisions take 30-45 days. Expedited reviews (for urgent medical situations) are completed within 72 hours. You can check status through the Aetna provider portal or by calling 888-321-3124.

What if Emflaza is non-formulary on my plan? Non-formulary drugs can still be covered through formulary exceptions. Document medical necessity and trial/failure of preferred alternatives (prednisone/prednisolone) to strengthen your exception request.

Can I request an expedited appeal in New Jersey? Yes, both Aetna internal appeals and New Jersey IHCAP external reviews offer expedited processes when delays could jeopardize health. Physician certification of urgency is required.

Does step therapy apply if I failed prednisone outside New Jersey? Medical records from any state count toward step therapy requirements. Ensure your new provider has complete documentation of previous steroid trials and side effects.

What happens if IHCAP overturns Aetna's denial? The external review decision is binding. Aetna must comply and cover the service as mandated by New Jersey statute (N.J.S.A. 26:2S-11). Coverage typically begins within 30 days of the decision.

How does Counterforce Health help with appeals? Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform ingests denial letters and clinical notes to draft point-by-point rebuttals aligned with each plan's specific rules, potentially improving your chances of approval.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Coverage decisions depend on your specific plan terms and clinical circumstances. Always consult your healthcare provider and insurance plan directly for personalized guidance. For additional help with New Jersey insurance appeals, contact the NJ Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

At Counterforce Health, we help patients, clinicians, and specialty pharmacies navigate complex prior authorization and appeals processes. Our platform creates targeted, evidence-backed appeals by analyzing denial letters alongside plan policies and clinical documentation, helping turn insurance obstacles into approval opportunities.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.